February 2026 Update on US regulatory review of Saphnelo subcutaneous administration in systemic lupus erythematosus The US Food and Drug Administration (FDA) issued a complete response letter (CRL) ...
China’s Ministry of Foreign Affairs (MOFA) on December 26, 2025, issued the country’s latest round of sanctions pursuant to its Anti-Foreign ...
The Human Development Index (HDI) is a tool to measure human prosperity. Learn how it works, as well as the criticisms and ...
The 2026 Report is the final installment in a trilogy on development through uncertainty, building on the 2023–24 HDR on political polarization and the 2025 HDR on AI-driven transformations. This ...
The 2026 Report is the final installment in a trilogy on development through uncertainty, building on the 2023–24 HDR on political polarization and the 2025 HDR on AI-driven transformations. This ...
This study on Bangladesh was undertaken to analyze the gender dimensions of climate change and the role of institutions in reducing gender gaps. The study was carried out in 20 sites covering 600 ...
Viet Nam’s investment in its youngest generation is fundamentally an investment in the country’s future human capital. Today, over 10 million Vietnamese children under age 6 (with another one million ...
Security teams often spend days manually turning long incident reports and threat writeups into actionable detections by ...
AMPLITUDE is the first clinical trial to evaluate potential therapies for patients with mHSPC and known HRR gene alterations, with positive results supporting the niraparib-based combination regimen ...
PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR UNITED STATES PATENT COVERING MASITINIB IN THE TREATMENT OF METASTATIC CASTRATE RESISTANT PROSTATE CANCER THIS POSITIVE DECISION FROM THE USA ...
Chordoma is a rare, treatment-resistant tumor with limited therapeutic options and a high rate of recurrence. In a recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results